What is the management of rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Rhabdomyolysis

Immediately initiate aggressive intravenous fluid resuscitation with 0.9% normal saline at 1 liter per hour to prevent acute kidney injury, which is the most critical intervention for reducing mortality and preserving renal function. 1, 2

Immediate Fluid Resuscitation

  • Start IV fluids at 1000 mL/hour of 0.9% normal saline immediately upon patient contact, establishing IV access in an accessible limb 2
  • Target a urine output of 300 mL/hour once bladder catheterization is established—this is the therapeutic goal that drives all fluid management decisions 1, 2, 3
  • For severe rhabdomyolysis (CK >15,000 IU/L), volumes greater than 6L per day may be required; for moderate cases, 3-6L per day is typically sufficient 1, 4
  • Avoid potassium-containing fluids and starch-based fluids entirely 2
  • Continue IV fluids until CK levels decrease below 1,000 U/L, urine output remains adequate, electrolytes normalize, and renal function stabilizes 2, 3

Electrolyte Monitoring and Management

  • Monitor electrolytes (particularly potassium, calcium, and phosphorus) every 6-12 hours 1, 2
  • Hyperkalemia is the most immediately life-threatening complication and can lead to cardiac arrhythmias and arrest—treat aggressively with standard protocols 1, 2
  • Repeated bioassessment should include plasma myoglobin, CK, and potassium measurements 1
  • Monitor for metabolic acidosis with arterial blood gas analysis in severe cases 1

Medication Review

  • Immediately discontinue any offending agents, particularly statins, which are a common cause with an incidence of 1.6 per 100,000 patient-years 1
  • Stop all dietary supplements associated with rhabdomyolysis risk, including red yeast rice (containing lovastatin), creatine monohydrate, wormwood oil, licorice, and Hydroxycut 1, 2
  • Avoid succinylcholine in the perioperative setting as it can exacerbate rhabdomyolysis 1

Compartment Syndrome Surveillance

  • Maintain high suspicion for compartment syndrome, which can both cause and complicate rhabdomyolysis 1, 4
  • Early signs include pain, tension, paresthesia, and paresis—these are the window for intervention 1, 4
  • Late signs (pulselessness and pallor) often indicate irreversible damage 1
  • Perform early fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic BP minus compartment pressure) is <30 mmHg 1, 4, 2

Renal Replacement Therapy Indications

  • Initiate dialysis early for: refractory hyperkalemia, severe metabolic acidosis, fluid overload, or persistently elevated CK levels after 4 days of adequate hydration 2
  • Acute kidney injury is the most significant complication and occurs particularly when CK exceeds 16,000 IU/L 5
  • Myoglobinuric renal failure requiring dialysis is a potential delayed complication 1

Pain Management Algorithm

  • First-line: Acetaminophen 500-1000 mg (onset 15-30 minutes, maximum 4-6 grams daily) as it avoids nephrotoxic effects 1
  • Avoid all NSAIDs (ibuprofen, ketoprofen, diclofenac, naproxen, mefenamic acid) due to gastrointestinal and renal toxicity 1
  • For severe pain unresponsive to acetaminophen: oral morphine 20-40 mg for opioid-naive patients 1
  • If acute kidney injury develops with eGFR <30 mL/min: switch to fentanyl or buprenorphine as the safest opioid choices 1
  • Provide round-the-clock dosing with rescue doses (10-15% of total daily dose) for breakthrough pain 1

Laboratory Workup

  • CK level at least 10 times the upper limit of normal is diagnostic 3
  • Complete blood count with differential to evaluate for infection or systemic processes 1
  • Liver function tests (AST, ALT, alkaline phosphatase) as transaminitis commonly occurs due to muscle enzyme release 1
  • Urinalysis showing brown color, cloudiness, and positive for blood without RBCs indicates myoglobinuria 1
  • Coagulation studies to evaluate for disseminated intravascular coagulation in severe cases 1

Special Considerations for Recurrent or Unexplained Cases

  • Consider genetic testing for RYR1 and CACNA1S gene sequencing (malignant hyperthermia susceptibility) in patients with exertional rhabdomyolysis or heat illness 1
  • Test for metabolic myopathies (CPT2, PYGM, ACADM, AMPD1, VLCAD genes) in recurrent rhabdomyolysis 1
  • Evaluate for SLCO1B1 gene mutations in statin-induced cases, as genetic factors increase risk 1
  • Consider autoimmune markers (ANA, ASMA, ANCA) if autoimmune myositis is suspected 1

Admission Criteria

  • Hospitalize patients with rhabdomyolysis who have immunocompromised state, significant pain requiring management, mental confusion, pulmonary infiltrates, abnormal spinal fluid findings, or specific organ failure 1
  • Most patients require admission; discharge may be appropriate only for very mild cases with CK trending down and normal renal function 6

Common Pitfalls to Avoid

  • Delayed fluid resuscitation is associated with higher risk of acute kidney injury—time is critical 1
  • Do not wait for laboratory confirmation if clinical suspicion is high; start fluids immediately 2
  • In trauma patients with simple contusion, CK elevation may peak 24-120 hours post-event without reflecting true rhabdomyolysis—repeat CK at 24 hours if clinical suspicion remains 1
  • Mortality rate is approximately 10% overall but significantly higher in patients who develop acute renal failure 5

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Rhabdomyolysis in Trauma Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rhabdomyolysis with Rash Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rhabdomyolysis: review of the literature.

Neuromuscular disorders : NMD, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.